Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05060341 · ClinicalTrials.gov registry record
Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia
A clinical trial of Radiation-induced Xerostomia, sponsored by MeiraGTx.
- Active
- Registry status
- 22
- Enrollment target
- 4
- Study locations
NCT05060341: Active study of Radiation-induced Xerostomia, sponsored by MeiraGTx.
NCT05060341 is a study of Radiation-induced Xerostomia that is active but no longer recruiting, run by MeiraGTx. The registered enrollment target is 22 participants. The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05060341, a study of Radiation-induced Xerostomia, is active but no longer recruiting, sponsored by MeiraGTx.
- ACTIVE NOT RECRUITING
- Registry status
- 22 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study is a long-term follow-up study for patients who have been administered AAV2hAQP1 in the Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity in Subjects with Radiation Induced Parotid Gland Hypofunction and Xerostomia
Primary Outcome
Safety
Conditions Studied
Study Locations (4)
California
- Leland Stanford Junior University - Stanford
Massachusetts
- Brigham and Women's Hospital - Boston
North Carolina
- Atrium Health - Charlotte
Ontario
- Health Sciences North - Northeast Cancer Center - Greater Sudbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2020-11-12 |
| Est. Completion | 2027-03 |
What the registry record for NCT05060341 still lists
NCT05060341 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 22 participants, a relatively small participant target.
The record links to 1 condition, with Radiation-induced Xerostomia appearing as the primary indexed condition, and to 0 interventions.
NCT05060341 reports a single indexed study location in California, Massachusetts, North Carolina.
Frequently Asked Questions
What is clinical trial NCT05060341 about?
NCT05060341 is a clinical study titled "Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia". This study is a long-term follow-up study for patients who have been administered AAV2hAQP1 in the Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity in Subjects with Radiation Induced Parotid Gland Hypofunction and Xerostomia
What is the current status of trial NCT05060341?
This trial is currently active not recruiting. The enrollment target is 22 participants. The study started on 2020-11-12. Estimated completion is 2027-03.
What conditions does trial NCT05060341 study?
This clinical trial studies the following conditions: Radiation-induced Xerostomia.
Who is sponsoring clinical trial NCT05060341?
This trial is sponsored by MeiraGTx, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05060341 being conducted?
This trial has 4 study locations across California, Massachusetts, North Carolina, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radiation-induced Xerostomia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI